Veterans’ RightsAn independent resource for veterans
← All decisions
Denied

The Veteran's atopic dermatitis affects less than five percent of his total body or exposed areas and is treated with topical medications. The Board finds that a compensable rating is not warranted as the use of topical corticosteroids does not qualify as systemic therapy.

The deciding factor: The use of topical corticosteroids did not result in side effects affecting areas of the body other than the Veteran's face and chest, and thus was considered topical rather than systemic therapy.

Claimed conditions
Atopic Dermatitis
How they argued it
Direct service connection
Exposure basis
None
Rating assigned
None in this decision
Decision date
May 12, 2021
Citation
21028788

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 21028788.

What this means for you

A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.